---
figid: PMC5400658__oncotarget-08-22203-g002
figlink: /pmc/articles/PMC5400658/figure/F2/
number: F2
caption: . The PI3K signaling pathway's key players and inhibitors under investigation
  in HNSCC trials.
pmcid: PMC5400658
papertitle: Dysregulations in the PI3K pathway and targeted therapies for head and
  neck squamous cell carcinoma.
reftext: Yi Cai, et al. Oncotarget. 2017 Mar 28;8(13):22203-22217.
pmc_ranked_result_index: '100110'
pathway_score: 0.9633384
filename: oncotarget-08-22203-g002.jpg
figtitle: Dysregulations in the PI3K pathway and targeted therapies for head and neck
  squamous cell carcinoma
year: '2017'
organisms:
- Homo sapiens
ndex: ebd8d30e-deaf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5400658__oncotarget-08-22203-g002.html
  '@type': Dataset
  description: . The PI3K signaling pathway's key players and inhibitors under investigation
    in HNSCC trials.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - PIK3CA
  - NMUR1
  - AKT1
  - AKT3
  - PIK3R4
  - PIK3R5
  - MTOR
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PDK4
  - PIK3R6
  - PDK2
  - PDK3
  - IMMT
  - PDK1
  - PTEN
  - PIK3R3
  - Temsirolimus
  - Ridaforolimus
  - SF1126
  - BYL-719
  - NVP-BYL719
  - Metformin
  - Sirolimus
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: GPCR/RTK
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: P101
  symbol: p101
  source: hgnc_alias_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: p87
  symbol: P87
  source: hgnc_alias_symbol
  hgnc_symbol: IMMT
  entrez: '10989'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Ridaforolimus
  source: MESH
  identifier: C515074
- word: SF1126
  source: MESH
  identifier: C526549
- word: BYL-719
  source: MESH
  identifier: C585539
- word: NVP-BYL719
  source: MESH
  identifier: C585539
- word: Metformin
  source: MESH
  identifier: D008687
- word: Sirolimus
  source: MESH
  identifier: D020123
diseases: []
figid_alias: PMC5400658__F2
redirect_from: /figures/PMC5400658__F2
figtype: Figure
---
